Loading company…
Riskpilot
← Back to search
Sign in
Get full access
RFSU Danmark ApS
APS
Active
CVR 44864452
Landgreven 3, st. th
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2024
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 2M
+1661% vs 2024
EBITDA margin
40.6%
+6976% vs 2024
Equity ratio
13.3%
Financial strength
Net profit 2025
DKK 611K
+10820% vs 2024
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
0M
2024
1M
+100%
2025
Key figures
Annual report 2025
Revenue
DKK 2M
+1661%
EBITDA
DKK 812K
+6976%
Net profit
DKK 611K
+10820%
Total assets
DKK 4,9M
+937%
Equity
DKK 657K
+1340%
Employees
1
—
Company information
Legal name
RFSU Danmark ApS
CVR number
44864452
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. maj 2024
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør og et medlem af bestyrelsen i forening eller af to medlemmer af bestyrelsen i forening.
Company purpose
Virksomhedens formål er engroshandel med medicinsk udstyr og apoteksvarer samt dermed forbunden virksomhed.
Contact
Address
Landgreven 3, st. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in København
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
0M
2024
2M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
1M
2025
Income statement
DKK thousands
Item
2024
2025
Revenue
114
2.001
Staff expenses
-102
-1.189
EBITDA
11
812
Depreciation & amort.
-0
-0
EBIT
11
812
Net financials
-4
-25
Profit before tax
7
787
Tax
2
176
Net profit
6
611
Balance sheet
DKK thousands
Item
2024
2025
Total assets
476
4.936
Equity
46
657
Long-term debt
0
0
Short-term debt
431
4.279
Total debt
431
4.279
Financial ratios
5-year trend
EBITDA margin
40.6%
This company
15.8%
Market median
+157% vs market
2024
2025
Equity ratio
13.3%
This company
38.2%
Market median
-65% vs market
2024
2025
Return on equity
93.1%
This company
18.4%
Market median
+406% vs market
2024
2025
Net profit margin
30.5%
This company
8.1%
Market median
+277% vs market
2024
2025
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
2024
2025
Debt / equity
6.52×
This company
0.62×
Market median
-952% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-05-27 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
RA
RFSU AKTIEBOLAG
Founder
Founder
2024
YA
Ylva Annika Strindlund Jerveland
Management
Management
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MA
My Anna Charlotte Olsson
Board of Directors
2024
AM
Anna Maria Windrup Levin
Board of Directors
2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
RFSU AKTIEBOLAG
Individual
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of RFSU Danmark ApS also hold positions in
0
other companies.
Person
Role here
Other companies
RFSU AKTIEBOLAG
Founder
0 companies
Ylva Annika Strindlund Jerveland
Management
0 companies
My Anna Charlotte Olsson
Board of Directors
0 companies
Anna Maria Windrup Levin
Board of Directors
0 companies